Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial
暂无分享，去创建一个
Y. Yazdanpanah | J. Timsit | L. Bouadma | C. Cagnot | B. Lina | F. Lescure | N. Néant | M. Lê | G. Peytavin | E. D’Ortenzio | J. Guedj | C. Fougerou | H. Esperou | N. Peiffer-Smadja | J. Poissy | C. Delmas | F. Mentré | A. Taburet | D. Belhadi | L. Moinot | C. Laouénan | C. Semaille | F. Ader | V. Icard | C. Burdet | L. Wittkop | A. Diallo | A. Dupont | F. Morfin-Sherpa | S. Le Mestre | A. Dechanet | J. Saillard | N. Mercier | Anissa Chair | Samira Laribi | Marion Noret | Oriane Puéchal | M. Schneider | J. Guillon | B. Leveau | S. Couffin‐Cadiergues | V. Petrov‐Sanchez | Marie‐Capucine Tellier | Basma Basli | J. Level | A. Gelley | D. Lebrasseur-Longuet | Florence Yazdan France François-Xavier Nathan Lila Julien J Ader Yazdanpanah Mentre Lescure Peiffer- | M. Noret | S. Couffin-cadiergues | S. Laribi | V. Petrov-sanchez